Institutional investors purchased a net $2.4 million shares of MORF during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 69.46% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SILVERARC CAPITAL MANAGEMENT LLC Bought 350.0 Thousand shares of Morphic Holding Inc
ASSENAGON ASSET MANAGEMENT SA (G... Bought 254.1 Thousand shares of Morphic Holding Inc
CANDRIAM BELGIUM SA Bought 160.5 Thousand shares of Morphic Holding Inc